Search results
Found 27 matches for
New ethical framework for coercive antimicrobial stewardship policies
Ethics, social science & humanities Research news
29 April 2024
Published in the journal Public Health Ethics, the research introduces an ethical framework for assessing the use of coercive antimicrobial stewardship policies to address the ‘silent pandemic’ of antimicrobial resistance.
Researchers enrol record number of patients for landmark plague trial
Research news Vaccines, treatments, diagnostics & trials
26 April 2024
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
New Pandemic PACT research programme launched
Ethics, social science & humanities Research news
21 March 2024
The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
Study reveals high number of persistent COVID-19 infections in the general population
Epidemiology & data Research news
21 February 2024
A new study – led by researchers at PSI – has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.
Vaccine trial for deadly Nipah virus launched
Nipah virus Research news Vaccines, treatments, diagnostics & trials
11 January 2024
Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.
Study reveals that duration of exposure to COVID-19 plays major role in risk of catching the virus
Epidemiology & data Research news
20 December 2023
Using data from 7 million people notified by the NHS COVID-19 contact tracing app, this is the first large-scale study to reveal how duration and proximity of contact with an infected person affects how COVID-19 is spread.
Nipah virus: How a neglected disease raises new ethical questions
Ethics, social science & humanities Nipah virus Research news
18 December 2023
New University of Oxford research brings to light important ethical considerations in Nipah virus outbreak control, its treatment, and research into vaccines.
Funders Roadmap is supporting better clinical trials
Ethics, social science & humanities Research news
14 December 2023
New framework helps funders to support coordinated, effective and equitable clinical trials in response to epidemics and pandemics.
Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa
Partner news Research news
16 November 2023
PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
Research news Vaccines, treatments, diagnostics & trials
2 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.
World-leading RECOVERY trial expands to investigate treatments for influenza
Research news Vaccines, treatments, diagnostics & trials
30 October 2023
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.
Researchers analyse UK COVID-19 Infection Survey data to tell the story of the virus' genomic evolution and spread
Epidemiology & data Research news
18 October 2023
Research published today brings together for the first time the epidemiology and evolution of the SARS-CoV-2 virus in the UK during the first three years of the pandemic – including how variants emerged and spread.
Global collaboration to develop next-generation COVID-19 and flu vaccines
News Research news Vaccines, treatments, diagnostics & trials
10 October 2023
The University of Oxford has launched a new global vaccine collaboration, backed by £8 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)
News Research news Vaccines, treatments, diagnostics & trials
18 September 2023
The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.
Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched
News Research news Vaccines, treatments, diagnostics & trials
11 September 2023
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
CEPI and University of Oxford to accelerate vaccine development against Disease X
News Research news Vaccines, treatments, diagnostics & trials
30 August 2023
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
£12 million investment for Future Vaccines Manufacturing Hub
News Research news Vaccines, treatments, diagnostics & trials
11 April 2023
A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
NHS COVID-19 app saved estimated 10,000 lives in its first year, new research finds
News Research news
22 February 2023
A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalisations and 9,600 deaths during its first year.
Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists
Awards Research news Vaccines, treatments, diagnostics & trials
9 December 2022
The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
Oxford's Ebola vaccine recommended for deployment against Uganda outbreak
News Research news Vaccines, treatments, diagnostics & trials
22 November 2022
A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.